Clinical Trial: A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07154290) titled 'A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)' on Aug. 26.

Brief Summary: This study will evaluate two study drugs called ubamatamab and REGN7075, to see if they can help treat advanced or metastatic Non-Small Cell Lung Cancer (NSCLC), and sarilumab, to evaluate to see if it can help with immune-related side effects from ubamatamab.

The study is looking at:

* How well ubamatamab and REGN7075 works

* The side effects that ubamatamab and REGN7075 might cause

* How much ubamatamab and REGN7075 is in the blood at different times

* If the...